Bank of New York Mellon Corp Sells 80,334 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Bank of New York Mellon Corp lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 9.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 790,587 shares of the company's stock after selling 80,334 shares during the quarter. Bank of New York Mellon Corp owned about 0.65% of Henry Schein worth $54,147,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. Investment Management Corp VA ADV bought a new stake in Henry Schein during the fourth quarter worth about $32,000. Rakuten Securities Inc. purchased a new position in shares of Henry Schein during the first quarter valued at approximately $34,000. UMB Bank n.a. boosted its position in shares of Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock worth $73,000 after purchasing an additional 201 shares in the last quarter. Menard Financial Group LLC purchased a new stake in shares of Henry Schein in the 4th quarter worth approximately $92,000. Finally, Canada Post Corp Registered Pension Plan purchased a new stake in shares of Henry Schein in the 4th quarter worth approximately $95,000. Institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Baird R W downgraded Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Robert W. Baird restated a "neutral" rating and set a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research note on Monday. Evercore ISI upped their target price on shares of Henry Schein from $72.00 to $78.00 and gave the stock an "in-line" rating in a research note on Wednesday, July 9th. Finally, Barrington Research reduced their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. Eight analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $78.36.

Henry Schein Stock Performance

Shares of HSIC stock traded down $1.32 on Wednesday, reaching $69.32. The stock had a trading volume of 2,134,933 shares, compared to its average volume of 1,735,704. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The stock has a market cap of $8.44 billion, a P/E ratio of 21.66, a price-to-earnings-growth ratio of 2.28 and a beta of 0.87. The company has a 50 day simple moving average of $71.73 and a 200 day simple moving average of $71.33.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The business had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same period last year, the firm posted $1.10 earnings per share. The business's revenue for the quarter was down .1% on a year-over-year basis. Equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.